期刊文献+

用CD133免疫磁珠分离脐血内皮祖细胞的实验研究 被引量:7

Isolation of endothelial progenitor cells from cord blood with CD133 immunomagnetic sorting
下载PDF
导出
摘要 目的:从脐血中分离、培养血管内皮祖细胞,研究内皮祖细胞的生长特性和诱导分化条件。方法:应用MACS磁球抗体标记法纯化脐血中的CD133+细胞,通过流式细胞仪、免疫细胞化学、免疫荧光等技术及形态学(光镜、电镜)观察研究内皮祖细胞;将细胞接种于添加(或未添加)VEGF、bFGF、干细胞因子(SCF)的含20%胎牛血清(FBS)的IMDM培养基中,观察内皮祖细胞的生长特性。结果:分离新鲜脐血所得CD133阳性细胞占单个核细胞的(1.41±1.14)%,经流式细胞仪鉴定CD133+细胞纯度为75%-85%;将分离细胞接种于纤维连接蛋白包被的24孔板内,培养1-2h即有细胞贴壁,7-10d可见贴壁细胞呈铺路石样排列;14d后细胞出现小圆形、梭形等多样性变化,可见毛细血管管腔样结构,电镜观察可见胞浆内典型的Weibel-Palade小体;在VEGF、bFGF、SCF存在条件下,检测贴壁细胞培养14d后细胞表面抗原表达情况:与培养开始时相比,祖细胞标志CD133和CD34阳性率呈明显下降趋势,分别由(77.0±3.3)%和(93.1±4.7)%降至(1.6±2.2)%和(37.4±4.9)%,P<0.05,内皮细胞特异性标志Flk-1表达明显增加,由(22.3±3.3)%增至(94.3±4.1)%,P<0.05,同时vWF抗原呈强阳性表达,阳性率为(77.9±3.3)%。结论:根据细胞表面特异性分子标志(CD133+/CD34+/Flk-1+)可以从脐血中分离出EPCs,EPCs可在体外一定的诱导因子作用下,培养7-10d分化为成熟内皮细胞。 AIM: To isolate, purify and differentiate endothelial progenitor cells from cord blood in vitro and to study their biological characteristics. METHODS: CD133^+ cells were selected from fresh cord blood mononuclear cells (MNC) by magnetic activated cell - sorting system ( MACS). EPC was studied by flow cytometry, immunocytochemistry and immunofluorescence staining, lsolated cells were cultured in IMDM medium supplemented with or without VEGF, bFGF, SCF. RESULTS: The percentage of CD133^+ cells of cord blood MNC was (1.41 ± 1.14)%, and purity was 75% - 85% (FACS method). CD133^+ cells were grown on fibronectin - coated chandrer slides in the presence of VEGF, bFGF, SCF. Within 1 - 2 hours of culture cells became adherent. On clay 7- 10, the adherent cells displayed a typical “cobblestone” morphology. After 14 days of culture, the adherent cells revealed a heterogeneous cell population, comprising small- sized round cells, spindle- like cells and formed tubelike structure. Weibel- Palade bodlies were shown on the transmission electron microscopy photomicrographs. Compared with the original, cell markers CD133 and CD34 decreased significantly (77.0% ± 3.3% to 1.6% ± 2.2% and 93.1% ± 4.7% to 37.4% ± 4.9%, P 〈 0.05), while Flk - 1 increased significantly (from 22.3% ± 3.3% to 94.3% ± 4.1%, P 〈 0.05) after 14 days of culture with VEGF, bFGF, SCF. Tbe vWF was strongly expressed (77.9% ± 3.3% ) on the 14th day later. CONCLUSION: Vascular endothelial progenitor cells were isolated from cord blood with specific expression of CD133/CD34/Flk - 1 . With the stimulation of the growth factors, seven - ten days after culture EPCs could be turned to endothelial cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第9期1675-1680,共6页 Chinese Journal of Pathophysiology
基金 国家"十五""211"工程重点学科建设基金 复旦大学青年科学基金 复旦大学上海医学院青年科学基金(No.JMF108001)
关键词 胎血 内皮祖细胞 细胞分离 纯化 分化 Fetol blood Endothelial progenitor cells Cell separation Purification Differentiation
  • 相关文献

参考文献10

  • 1Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function[J]. Nat Med, 2001, 7(4): 430-436.
  • 2Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells[J]. Circulation, 2002, 105(25): 3017-3024.
  • 3郑玮,杨向红.骨髓源性血管内皮前体细胞与出生后生理性和病理性血管形成[J].中国病理生理杂志,2004,20(9):1734-1738. 被引量:3
  • 4Hristov M, Erl W, Weber PC. Endothelial progenitor cells isolation and characterization[J]. Trends Cardiovasc Med, 2003, 13(5): 201-206.
  • 5金惠铭,李先涛.血管新生与疾病[J].中国微循环,2001,5(3):173-177. 被引量:17
  • 6Eggermann J, Kliche S, Jarmy G, et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood[J]. Cardiovasc Res, 2003, 58(2): 478-486.
  • 7Quirici N, Soligo D, Caneva L, et al. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells[J]. Br J Haematol, 2001, 115(1): 186-194.
  • 8Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275(14): 964-967.
  • 9Yin AH, Miraglia S, Zanjani ED, et al. AC133,a novel marker for human hematopoietic stem and progenitor cells[J]. Blood, 1997, 90(12): 5002-5012.
  • 10Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes[J]. Circulation, 2003, 107(7): 1024-1032.

二级参考文献31

  • 1Crosby JR, Kaminski WE, Schatteman G, et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation[ J]. Circ Res, 2000,87 (9): 728- 730.
  • 2Davidoff AM, Ng CY, Brown P. Bone marrow- derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice[J]. Clin Cancer Res, 2001, 7(9) :2870- 2879.
  • 3Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone- marrow- derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth[J]. Nat Med,2001, 7(11):1194- 1201.
  • 4Wemer N, Priller J, Laufs U, et al. Bone marrow - derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3 - hydroxy - 3 - methylglutaryl coenzyme a reductase inhibition[J]. Arteriocler Tmomb Vasc Biol, 2002, 2
  • 5Rivard A, Fabre JE, Saver M, et al. Age - dependent impairment of angiogenesis[J]. Circulation, 1999, 99(1):111- 120.
  • 6Rivard A, Silver M, Chen D, et al. Rescue of diabetes - related impairment of angiogenesis by intramuscular gene therapy with adeno- VEGF[J]. Am J Pathol, 1999, 154(2):355-363.
  • 7Kalka C, Masuda H, Takahashi T, et al. Transplantation ofex vivo expanded endothelial progenitor cells for therapeutic neovascularization[ J]. Proc Natl Acad Sci USA, 2000, 97(7) :3422.
  • 8Natori T, Sara M, Washida M,et al. G- CSF stimulates angiogenesis and promotes tumor growth: potential contribution ofbone marrow- derived endothelial progenitor cells [ J ].Biochem Biophys Res Commun, 2002, 297(4):1058- 1061.
  • 9Chen YX, Nakashima Y, Tanaka K, et al. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries[J]. Arterioscler Thromb Vasc Biol, 1999,19(1): 131- 139.
  • 10Risau W. Mechanisms of angiogenesis [ J ]. Nature, 1997,386(6626) :671 - 674.

共引文献18

同被引文献82

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部